We are seeking an experienced and dynamic Project Manager to lead and deliver IT projects that bridge the gap between business objectives and technology solutions. The ideal candidate will be responsible for managing the full project lifecycle, ensuring that business requirements are translated into effective IT deliverables, and fostering collaboration between stakeholders from both domains. This is a full-time, hybrid position out of our Sandy Springs office with a move to Alpharetta in 2026.
Key Responsibilities:
Qualifications:
Skills:
Travel Requirement:
Physical Requirements and Work Conditions
The physical demands described here are representative of those that must be met by an employee to successfully perform the essential functions of the job. Reasonable accommodations may be made to enable individuals with disabilities to perform these functions.
Specific requirements may vary by role. Contact an HR representative for details related to the position.
Our credentials
Kuros is a Swiss-headquartered biotech company, listed on the SIX Swiss Stock Exchange since 2016 (under symbol KURN). With additional operations in the Netherlands and the USA, we continue to grow our global team.
To deliver the ideal bone graft, you need the highest quality and quantity of scientific evidence behind it. We believe that this is a key differentiator for Kuros, given the urgent need to advance bone healing.
Kuros Biosciences is an equal opportunity employer that is committed to diversity and inclusion in the workplace. We prohibit discrimination and harassment of any kind based on race, color, sex, religion, sexual orientation, national origin, disability, genetic information, pregnancy, or any other protected characteristic as outlined by federal, state, or local laws. Kuros Biosciences complies with GDPR and the California Consumer Privacy Act (CCPA). View our CCPA Notice here.

OUR PURPOSE
Kuros Biosciences is on a mission to discover, develop and deliver innovative biologic technologies.
OUR CREDENTIALS
Kuros is a Swiss-headquartered biotech company, listed on the SIX Swiss Stock Exchange since 2016 (under symbol KURN). With additional operations in the Netherlands and the USA, we continue to grow our global team.
To deliver the ideal bone graft, you need the highest quality and quantity of scientific evidence behind it. We believe that this is a key differentiator for Kuros, given the urgent need to advance bone healing.
• Listing on the SIX Swiss Exchange under the symbol KURN since 2016
• A commercial & research footprint that spans >20 markets
• Dozens of clinical and scientific expert advisers
• >25 orthobiologics-related patents
• >400 patients evaluated in Level I, randomized controlled clinical trials
• >20 well-controlled Level I-IV clinical trials initiated, including 6 that are complete¹
• Published Level I evidence published in 𝑆𝑝𝑖𝑛𝑒
CONTACT KUROS TO FIND OUT MORE >>>>